Dipyrone-related granulocytopenia. Case report
Rev. colomb. anestesiol; 46 (4), 2018
Abstract Introduction: Dipyrone has been positioned in several countries as one of the first over-the-counter options for pain management. Its possible adverse effects are known worldwide; among them, agranulocytosis is the most lethal, with a mortality of approximately 10% and an associated risk of 1 p...